Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis

NCT03441789 is registered in ClinicalTrials.gov with L.H. Kircik, M.D. as lead sponsor.

NCT NCT03441789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03441789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis
Lead sponsor
L.H. Kircik, M.D.
Phase
Phase 4
Overall status
Completed
Start date
September 18, 2017
Completion date
October 22, 2018
Enrollment
28 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis